Medicare GLP-1 Bridge Program: $50/Month Cost Guide
This August, eligible Medicare beneficiaries can access the weight-loss drugs Wegovy or Zepbound for a flat $50/month, a dramatic reduction from list prices of roughly $1,000 to $1,400 per month. This new Medicare GLP-1 Bridge Program cost, launched in mid-2026, offers significant savings for qualifying seniors.
How This Was Verified
This article is based on the official CMS announcement, Amazon Pharmacy’s program FAQ, and Reuters reporting. The launch date, $50 copay amount, program window, and specific eligibility exclusions were cross-checked against these primary sources, all verified live as of August 2026. We did not independently confirm the CVS and Walmart rollout details beyond the Reuters reporting.
How the Medicare GLP-1 Bridge Program Works
The Medicare GLP-1 Bridge Program is a CMS demonstration running from July 1, 2026, to December 31, 2027, offering a flat $50 monthly copay for 28- or 30-day supplies of Wegovy or Zepbound to eligible Part D beneficiaries. The copay is processed outside your standard Part D plan and does not count toward your deductible or TrOOP limit. (CMS)
Who Is Eligible — and Who Is Not
Eligibility is strict and based on the drug’s use and your existing coverage. The program is for weight-loss use only. You are not eligible if the drug would be coverable under your Part D plan for another diagnosis, such as type 2 diabetes, heart disease, sleep apnea, or liver disease. Certain medications are explicitly excluded.
| Eligible Medications | Excluded Medications & Uses |
|---|---|
| Wegovy (for weight loss) | Ozempic, Mounjaro |
| Zepbound (28/30-day supply pens) | Single-dose Zepbound vials |
| For patients with no overlapping Part D coverage for a related condition | For treatment of a comorbid condition covered by Part D |
How Much Does the Medicare GLP-1 Bridge Program Cost?
The Medicare GLP-1 Bridge Program cost is a flat $50 per month. The standard list price for these medications ranges from approximately $1,000 to $1,400 per month, meaning the program reduces eligible patients’ costs by up to ~95%. Crucially, this $50 payment is a flat copay and does not count toward your Part D plan’s deductible or TrOOP limit.
Amazon, CVS, and Walmart: Where You Can Fill
Amazon Pharmacy began dispensing medications through the program on August 6, 2026. That same week, CVS and Walmart announced parallel moves to offer the same $50/month copay, according to Reuters. Amazon’s system automates eligibility checks and prior authorization for a faster turnaround.
What the Program Does Not Cover (and What Else Is Changing)
The Medicare GLP-1 Bridge Program excludes Ozempic, Mounjaro, single-dose Zepbound vials, and any use other than weight loss. Only Wegovy and Zepbound in 28- or 30-day supplies qualify for eligible beneficiaries.
In separate cost news, CMS set 2027 Part D numbers on July 28 — a $296.05 national average monthly bid amount and a $41.33 base beneficiary premium — and is ending the premium stabilization subsidy (CMS fact sheet; KFF analysis). The INSULIN Act, which would cap private-market insulin at $35/month starting in 2027, passed the Senate HELP committee but is legislation in progress, not yet law (Forbes).
5 Steps to Check Your Eligibility Today
- Confirm your Medicare Part D enrollment status through your plan documents or online account.
- Verify you are seeking the drug for weight loss and not for a condition covered under your Part D plan.
- Check your current medications to ensure you do not have coverage for Ozempic, Mounjaro, or another related diagnosis.
- Visit a participating pharmacy’s website (like Amazon, CVS, or Walmart) to begin the eligibility verification process.
- Speak with your doctor to discuss if Wegovy or Zepbound is an appropriate option for your weight-management goals.
FAQ
Does the $50 copay count toward my Part D deductible?
No. The $50 copay for the Medicare GLP-1 Bridge Program is processed outside your standard Part D plan. Payments made through this program do not count toward your annual plan deductible or your True Out-of-Pocket (TrOOP) spending limit, as specified by the CMS program details.
Can I get Ozempic through the Medicare GLP-1 Bridge Program?
No. The program explicitly excludes Ozempic and Mounjaro. It only covers Wegovy and Zepbound pens in a 28- or 30-day supply for the indication of weight loss, according to the Amazon Pharmacy FAQ.
How long will the Medicare GLP-1 Bridge Program last?
The program is a CMS demonstration with a defined timeline. It launched on July 1, 2026, and is scheduled to run through December 31, 2027. Its future beyond that date is not yet determined.
Where to Go Next
For official details, visit the CMS Medicare GLP-1 Bridge Program page. To start the enrollment process with a retailer, see the Amazon Pharmacy Bridge Program FAQ. To manage your broader healthcare finances, explore our health finance tools. For related analysis, see our GoodRx pricing comparison and our ACA 2027 premium analysis.